物质信息
ID:181437
名称和标识
别名
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dioneBudesonide
IUPAC传统名
budesonide
IUPAC标准名
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
化合物性质
产品相关信息
纯度
≥99%
安全信息
德国WGK号
3
RTECS编号
TU3723000
个人保护装置
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
药理学性质
相关基因信息
human ... IFNG(3458), IL5(3567)rat ... Nr3c1(24413)
描述信息
Biochem/physiol Actions
Budesonide is a second generation glucocorticoid with low systemic absorption. It is used as an anti-inflammatory agent in the treatment of asthma, rhinitis, and inflammatory bowel disease. It inhibits the expression of chemokine mRNA and production of eotaxin and RANTES protein in primary human bronchial epithelial cells. Budesonide is currently in clinical trials for the prevention of lung cancer. It shows inhibitory effects on benzo[a]pyrene-induced carcinogenesis of the lung in mice.
Budesonide is a second generation glucocorticoid with low systemic absorption. It is used as an anti-inflammatory agent in the treatment of asthma, rhinitis, and inflammatory bowel disease. It inhibits the expression of chemokine mRNA and production of eotaxin and RANTES protein in primary human bronchial epithelial cells. Budesonide is currently in clinical trials for the prevention of lung cancer. It shows inhibitory effects on benzo[a]pyrene-induced carcinogenesis of the lung in mice.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据